Skip to main content
Premium Trial:

Request an Annual Quote

Rosalyn Yalow Dies

Rosalyn Yalow, who won the Nobel Prize in Medicine, has died, reports The New York Times. She was 89. At a time when women were discouraged from entering the science, Yalow received her doctorate in nuclear physics and then taught at Hunter College in New York City; she could not get a research position, the Times adds. She then moved to the Bronx Veterans Administration Hospital and began working with Solomon Berson. Together, they developed radioimmunoassays, and found that antibodies could recognize molecules as small as insulin, a finding that was regarded with skepticism. For this work developing radioummunassays, Yalow was the second woman to win the Nobel in medicine. "We are witnessing the birth of a new era of endocrinology, one that started with Yalow," said the Karolinska Institute in Sweden upon awarding her the Nobel.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.